Laura Sepp-Lorenzino

Laura Sepp-Lorenzino

Company: Intellia Therapeutics

Job title: Chief Scientific Officer

Seminars:

Live Panel Q&A – Ask Speakers your Burning Questions 4:45 pm

Read more

day: Day Two

Transforming Medicine: In Vivo Therapeutic Genome Editing via Transient Expression of CRISPR/Cas9 3:55 pm

Intellia Therapeutics is a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo Applying modular platform advancements across multiple in vivo targets in the liver and other tissues Leveraging a lipid nanoparticle formulation of mRNA and guide RNA for efficient and transient expression of the genome…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.